By Stephen Daniells
The safety and efficacy of Sabinsa's proprietary blend of non-animal sourced enzymes for people with dyspepsia are supported by results of a new randomized, double-blind, placebo-controlled study.
By NFS Correspondent, 17 September 2018
A randomized, double-blind, placebo-controlled study published in the peer reviewed Journal of Medicinal Foods provided clinical evidence supporting the safety and efficacy of Sabinsa's multi-enzyme complex DigeZyme, a proprietary blend of non-animal sourced enzymes, in the management of dyspeptic symptoms in patients with functional dyspepsia.